PRRT2 and Alzheimer disease: Our lab has previously shown that increased Arc expression induced by preconditioning with the PKCɛ activator, ψɛ-receptor of activated C kinase (ψɛRACK), is necessary for neuroprotection against ischemia and the PKCɛ-mediated delay to AD [34].